63539-336 : Cibinqo 100 mg Oral Tablet, Film Coated
| NDC: | 63539-336 |
| Labeler: | U.S. Pharmaceuticals |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Cibinqo |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA213871 |
| Rev. Date: |
NDC Package Codes:
- 63539-336-14: 14 TABLET, FILM COATED IN 1 BOTTLE (63539‑336‑14)
Active Ingredients:
- Abrocitinib
Dosage Strength:
- 100 mg
Pharmaceutical Classes:
- Janus Kinase Inhibitor [EPC]
- Janus Kinase Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 63539-236 Cibinqo 50 mg Oral Tablet, Film Coated by U.S. Pharmaceuticals
- 63539-436 Cibinqo 200 mg Oral Tablet, Film Coated by U.S. Pharmaceuticals
- 0069-0235 Cibinqo 50 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
- 0069-0335 Cibinqo 100 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
- 0069-0435 Cibinqo 200 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 63539-334Next: 63539-421 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.